These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 13214457)

  • 1. Experiences in treating coronary and peripheral vascular diseases.
    FRIEDLANDER HS
    N Y State J Med; 1954 Dec; 54(24):3396-400. PubMed ID: 13214457
    [No Abstract]   [Full Text] [Related]  

  • 2. [The biological and therapeutic action of Triparanol].
    RAVINA A
    Presse Med (1893); 1960 Oct; 68():1700-1. PubMed ID: 13739904
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lanthasol aerosol in the treatment of obliterating peripheral arterial diseases and in coronary disease].
    NARDI FL
    Gazz Med Ital; 1958 Aug; 117(8):333-9. PubMed ID: 13574395
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic activity of cyclospasmol (3,5,5-trimethylcyclohexanol mandelic ester) in coronary & peripheral vascular diseases; casuistic contribution].
    BALLERINI C; FIORE G
    Gazz Med Ital; 1959 Apr; 118(4):136-41. PubMed ID: 13664047
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications, limits and future of epidural spinal cord electrical stimulation for coronary and peripheral artery disease].
    Gersbach P; Gardaz JP; Ferrari E; Haesler E; von Segesser LK
    Rev Med Suisse; 2008 Mar; 4(150):797-804. PubMed ID: 18476650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant peripheral arterial disease and coronary artery disease: therapeutic opportunities.
    Bittl JA; Hirsch AT
    Circulation; 2004 Jun; 109(25):3136-44. PubMed ID: 15226231
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary and peripheral interventions: an update.
    Lüscher TF
    Eur Heart J; 2016 Apr; 37(14):1085-7. PubMed ID: 27056341
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the clinical use of inactivated kallikrein].
    WELKOBORSKY E
    Ther Ggw; 1960 May; 99():239-42. PubMed ID: 13843839
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring antiplatelet therapy during peripheral vascular and coronary interventions.
    Mahmud E; Ang L
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):56-63. PubMed ID: 17482101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution to the study of a pyrimido-pyrimidine derivative].
    LOPEZ MERINO V; ALGARRA GONZALEZ F; PONS ESPANA E
    Med Esp; 1961 Sep; 46():204-13. PubMed ID: 14466606
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vasodilator treatment with a derivative of beta-phenylethylamine. Results in 5 cases of arterial syndromes].
    DULAC JF; MANY P; PICARD P
    Presse Med (1893); 1959 Sep; 67():1546-7. PubMed ID: 13818551
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with the complex therapy of peripheral vascular diseases].
    ABERLE L; HAJDU J; VARGA F; SZOOR J
    Orv Hetil; 1958 Nov; 99(46):1613-5. PubMed ID: 13613803
    [No Abstract]   [Full Text] [Related]  

  • 13. [Personal experiences with Ro 2-3248 in peripheral vascular diseases].
    INTEBI E; BRADLEY CA
    Dia Med; 1957 Nov; 29(84):3110 passim. PubMed ID: 13490197
    [No Abstract]   [Full Text] [Related]  

  • 14. Who should treat patients with peripheral arterial disease - the vascular specialist.
    Sillesen H
    Eur J Vasc Endovasc Surg; 2002 Jul; 24(1):1-3. PubMed ID: 12127841
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy for arterial disease: is it hype or is there hope? New and promising treatments were on the map several years ago, but clinical applications so far have proven elusive.
    Heart Advis; 2007 Apr; 10(4):9. PubMed ID: 17494203
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
    Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ
    Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral atherectomy: a critical review.
    Bunting TA; Garcia LA
    J Interv Cardiol; 2007 Dec; 20(6):417-24. PubMed ID: 18042047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of peripheral vascular disease on long-term survival after coronary artery bypass graft surgery.
    Chu D; Bakaeen FG; Wang XL; Dao TK; LeMaire SA; Coselli JS; Huh J
    Ann Thorac Surg; 2008 Oct; 86(4):1175-80. PubMed ID: 18805156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery.
    O'Rourke DJ; Quinton HB; Piper W; Hernandez F; Morton J; Hettleman B; Hearne M; Nugent W; O'Connor GT; Malenka DJ;
    Ann Thorac Surg; 2004 Aug; 78(2):466-70; discussion 470. PubMed ID: 15276497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiences with butedrine in the treatment of peripheral circulation disorders].
    WEGNER W
    Z Gesamte Inn Med; 1959 Jan; 14(1):37-9. PubMed ID: 13660103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.